Niox Group (NIOX)

Sector:

Health Care

Index:

FTSE AIM 50

68.20p
   
  • Change Today:
      0.40p
  • 52 Week High: 75.00
  • 52 Week Low: 54.40
  • Currency: UK Pounds
  • Shares Issued: 420.87m
  • Volume: 938,855
  • Market Cap: £287.03m
  • Beta: 0.00

Niox Group Overview

Niox Group is a specialty biopharmaceutical company focused on the development and commercialisation of a range of immunotherapy product candidates for the treatment of allergy.

Key Personnel

CEO: Jonathan Emms
CFO: Sarah Duncan
Independent Non-Executive Director: Sharon Curran
Non-Executive Chairman: Ian Johnson
Senior Independent Director: Garry Watts
Non-Executive Dir: Nicholas Mills, Robert (Rob) Graham Naylor

Contact Details

Address: Magdalen Centre, 1 Robert Robinson Ave, The Oxford Science Park, Oxford, England, United Kingdom, OX4 4GA
Phone: +44 (0)3303 309 356
Fax: +44 (0)7092 987560
Website: http://www.niox.com/

Listings

Sector: Health Care(LSE)
Index: FTSE AIM All-Share, FTSE AIM 50, FTSE AIM 100
ISIN: GB00BJVD3B28

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Niox Group Market Data

Currency UK Pounds
Share Price 68.20p
Change Today 0.40p
% Change 0.59 %
52 Week High 75.00
52 Week Low 54.40
Volume 938,855
Shares Issued 420.87m
Market Cap £287.03m
Beta 0.00

Niox Group Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
93.19% below the market average93.19% below the market average93.19% below the market average93.19% below the market average93.19% below the market average
84.62% below the sector average84.62% below the sector average84.62% below the sector average84.62% below the sector average84.62% below the sector average
Price Trend
12.31% below the market average12.31% below the market average12.31% below the market average12.31% below the market average12.31% below the market average
44.83% above the sector average44.83% above the sector average44.83% above the sector average44.83% above the sector average44.83% above the sector average
Income
54.72% below the market average54.72% below the market average54.72% below the market average54.72% below the market average54.72% below the market average
50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average
Growth
78.79% above the market average78.79% above the market average78.79% above the market average78.79% above the market average78.79% above the market average
50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average

What The Brokers Say

Strong Buy 3
Buy 2
Neutral 0
Sell 0
Strong Sell 0
Total 5
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Niox Group Dividends

  Latest Previous
  Final Final
Ex-Div 21-May-26 15-May-25
Paid 22-Jun-26 16-Jun-25
Amount 1.55p 1.25p

Trades for 14-Oct-2026

Time Volume / Share Price
16:35 1,448 @ 68.20p
16:35 69 @ 68.20p
16:35 99 @ 68.20p
16:35 126 @ 68.20p
16:35 122 @ 68.20p

Niox Group Key Personnel

CEO Jonathan Emms
CFO Sarah Duncan

Top of Page